metformin has been researched along with Glaucoma, Suspect in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, L | 1 |
| Zhang, X | 1 |
| Zhao, Y | 1 |
| Gang, X | 1 |
| Zhou, T | 1 |
| Han, J | 1 |
| Cao, Y | 1 |
| Qi, B | 1 |
| Song, S | 1 |
| Wang, X | 1 |
| Liang, Y | 1 |
| Ma, J | 1 |
| Liu, W | 1 |
| Hunter, A | 1 |
| Zhang, W | 1 |
2 other studies available for metformin and Glaucoma, Suspect
| Article | Year |
|---|---|
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals.
Topics: Animals; Cells, Cultured; Glaucoma; Glaucoma, Open-Angle; Humans; Integrins; Metformin; Mice; Ocular | 2023 |
Performing meta-analysis with incomplete statistical information in clinical trials.
Topics: Antihypertensive Agents; Cholesterol, LDL; Clinical Trials as Topic; Data Interpretation, Statistica | 2008 |